计数结局的两阶段随机试验设计:检验治疗、偏好与自我选择效应
两阶段随机试验设计可同时检验治疗效应、患者偏好效应与选择效应,但现有方法仅适用于连续和二分类结局。本文将模型扩展至计数结局,推导了偏好、选择和治疗效应的检验统计量,给出各效应的闭式样本量公式,并通过模拟展示非分层与分层设计的性质,最后以临终抗菌药物使用为例说明方法适用性。
要点
- 两阶段随机设计可同时评估治疗效应、偏好效应与选择效应。
- 本文将两阶段设计的方法学从连续和二分类结局扩展至计数结局。
- 推导了计数结局下偏好、选择和治疗效应的检验统计量及闭式样本量公式。
核心结论
- 将两阶段随机试验设计的方法学扩展至计数结局,可检验治疗、偏好与自我选择效应。
研究设计与样本
- 方法学扩展研究,推导计数结局下偏好、选择和治疗效应的检验统计量及闭式样本量公式。
- 通过模拟展示非分层与分层设计的性质,并以临终抗菌药物使用为例说明方法适用性。
主要发现
- 推导出计数结局下偏好、选择和治疗效应的检验统计量。
- 给出各效应的闭式样本量公式。
- 模拟展示了非分层与分层设计的性质。
临床怎么用
- 为以计数结局为终点、需评估患者偏好与选择效应的两阶段随机试验提供设计与样本量计算方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
While the traditional clinical trial design lays emphasis on testing the treatment effect between randomly assigned groups, it ignores the role of patient preference for a particular treatment in the trial. Yet, for healthcare providers who seek to optimize the patient-centered treatment strategy, the evaluation of a patient's psychology toward each treatment could be a key consideration. The two-stage randomized trial design allows researchers to test patient's preference and selection effects, in addition to the treatment effect. The current methodology for the two-stage design is limited to continuous and binary outcomes; this article extends the model to include count outcomes. The test statistics for preference, selection, and treatment effects are derived. Closed-form sample size formulae are presented for each effect. Simulations are presented to demonstrate the properties of the unstratified and stratified designs. Finally, we apply methods to the use of antimicrobials at the end of life to demonstrate the applicability of the methods.
引用
- Shi Y, Cameron B, Gu X, et al. Two-stage randomized trial design for testing treatment, preference, and self-selection effects for count outcomes. Stat Med. 2020. PMID: 32875582. doi:10.1002/sim.8686
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。